Retatrutide 10 mg — Lyophilized Vial 10 mg · 1 vial

What is Retatrutide?

Retatrutide is a synthetic peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. These signaling systems help regulate glucose handling, food intake and energy metabolism.

Biological activity

Retatrutide combines three receptor activities within one molecule. This distinguishes it from single-receptor GLP-1 agents and dual GIP/GLP-1 agents. Researchers examine how their combined signaling changes appetite-related and metabolic outcomes.

Purpose and areas of study

Its main research areas include body-weight regulation, glucose control and metabolic disease. A randomized phase 2 trial in adults with obesity reported substantial weight reductions with the investigational formulation, supporting further clinical investigation of the molecule.

Evidence context

Human trials used defined investigational formulations. Their results do not verify the identity, clinical effects or safety of this research vial.

Product presentation

One lyophilized vial. Labeled content: 10 mg.

Scientific references

PubMed 37366315

Research-use information

All information on this page is provided for scientific education and research purposes only. This product is intended exclusively for laboratory research and is not for human or veterinary use. The information is not medical advice or a claim of therapeutic benefit.